GoHealth (GOCO)
(Delayed Data from NSDQ)
$9.54 USD
-0.46 (-4.60%)
Updated Sep 23, 2024 03:59 PM ET
After-Market: $9.62 +0.08 (0.84%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth F Momentum C VGM
Income Statements
Fiscal Year end for GoHealth, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 735 | 632 | 1,062 | 877 | 540 |
Cost Of Goods | 159 | 188 | 239 | 199 | 170 |
Gross Profit | 576 | 444 | 823 | 678 | 370 |
Selling & Adminstrative & Depr. & Amort Expenses | 657 | 763 | 1,313 | 743 | 403 |
Income After Depreciation & Amortization | -82 | -319 | -489 | -65 | -33 |
Non-Operating Income | 0 | 0 | -11 | 0 | 0 |
Interest Expense | 69 | 57 | 34 | 33 | 8 |
Pretax Income | -151 | -376 | -534 | -97 | -41 |
Income Taxes | 0 | 1 | 0 | 0 | 0 |
Minority Interest | -88 | -228 | -345 | -53 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -151 | -376 | -534 | -97 | -41 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -63 | -149 | -189 | -44 | -41 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 37 | -209 | 7 | 36 | 1 |
Depreciation & Amortization (Cash Flow) | 119 | 110 | 496 | 101 | 33 |
Income After Depreciation & Amortization | -82 | -319 | -489 | -65 | -33 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 9.29 | 8.45 | 7.07 | 5.62 | NA |
Diluted EPS Before Non-Recurring Items | -5.95 | -14.76 | 17.69 | 37.63 | NA |
Diluted Net EPS (GAAP) | -7.19 | -17.72 | -26.84 | -3.30 | NA |
Fiscal Year end for GoHealth, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 105.87 | 185.60 | 276.70 | 132.04 | 142.78 |
Cost Of Goods | 20.68 | 38.01 | 41.09 | 35.99 | 36.42 |
Gross Profit | 85.19 | 147.59 | 235.61 | 96.05 | 106.36 |
SG&A, R&D, and Dept/Amort Expenses | 125.80 | 151.62 | 220.55 | 134.02 | 159.38 |
Income After SG&A, R&D, and Dept/Amort Expenses | -40.61 | -4.03 | 15.06 | -37.97 | -53.02 |
Non-Operating Income | -0.65 | 0.57 | 0.78 | -0.77 | -0.02 |
Interest Expense | 18.10 | 17.95 | 17.75 | 17.57 | 17.27 |
Pretax Income | -59.35 | -21.42 | -1.91 | -56.31 | -70.30 |
Income Taxes | -0.04 | -0.07 | 0.38 | -0.11 | -0.07 |
Minority Interest | -33.32 | -12.13 | -1.07 | -32.29 | -41.29 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -59.31 | -21.35 | -2.29 | -56.20 | -70.23 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -26.00 | -9.22 | -1.23 | -23.91 | -28.94 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 9.97 | 9.72 | 9.58 | 9.49 | 9.12 |
Diluted EPS Before Non-Recurring Items | -0.75 | -0.89 | 0.60 | -2.61 | -1.77 |
Diluted Net EPS (GAAP) | -2.70 | -1.04 | -0.19 | -2.61 | -3.27 |